Jane Street’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$322K Sell
1,907
-112,844
-98% -$19.3M ﹤0.01% 9087
2025
Q4
$19.4M Sell
114,751
-171,911
-60% -$27.9M ﹤0.01% 1649
2025
Q3
$41.4M Buy
286,662
+280,048
+4,234% +$38.2M 0.01% 1065
2025
Q2
$837K Sell
6,614
-249,550
-97% -$30.6M ﹤0.01% 5957
2025
Q1
$32.8M Sell
256,164
-1,699,033
-87% -$230M 0.01% 940
2024
Q4
$258M Buy
1,955,197
+518,931
+36% +$73M 0.06% 197
2024
Q3
$209M Buy
1,436,266
+452,038
+46% +$65.4M 0.05% 217
2024
Q2
$135M Buy
984,228
+879,388
+839% +$117M 0.03% 306
2024
Q1
$14.4M Buy
+104,840
New +$14.3M ﹤0.01% 1472
2023
Q4
Sell
-215,522
Closed -$26.4M 9446
2023
Q3
$26.4M Sell
215,522
-11,192
-5% -$1.42M 0.01% 903
2023
Q2
$28.8M Sell
226,714
-15,090
-6% -$1.96M 0.01% 910
2023
Q1
$31.2M Sell
241,804
-760,750
-76% -$99.6M 0.01% 729
2022
Q4
$132M Buy
1,002,554
+50,999
+5% +$6.59M 0.06% 226
2022
Q3
$111M Buy
951,555
+95,541
+11% +$11.9M 0.05% 252
2022
Q2
$101M Buy
856,014
+202,261
+31% +$24M 0.04% 313
2022
Q1
$85.2M Buy
653,753
+488,689
+296% +$63.7M 0.03% 455
2021
Q4
$25.2M Buy
165,064
+157,010
+1,949% +$24.3M 0.01% 1021
2021
Q3
$1.3M Sell
8,054
-66,222
-89% -$11.1M ﹤0.01% 5376
2021
Q2
$12.2M Buy
74,276
+70,506
+1,870% +$10.9M ﹤0.01% 1504
2021
Q1
$568K Sell
3,770
-17,795
-83% -$2.83M ﹤0.01% 6570
2020
Q4
$3.27M Buy
21,565
+18,336
+568% +$2.62M ﹤0.01% 2710
2020
Q3
$437K Sell
3,229
-274,313
-99% -$37.2M ﹤0.01% 5352
2020
Q2
$37.9M Buy
277,542
+199,077
+254% +$25.4M 0.03% 454
2020
Q1
$8.45M Buy
78,465
+68,693
+703% +$7.91M 0.01% 851
2019
Q4
$1.18M Sell
9,772
-262,850
-96% -$29.3M ﹤0.01% 2554
2019
Q3
$27.1M Sell
272,622
-558
-0.2% -$58.4K 0.04% 285
2019
Q2
$29.8M Buy
273,180
+255,220
+1,421% +$27.1M 0.05% 274
2019
Q1
$2.01M Buy
17,960
+1,370
+8% +$150K ﹤0.01% 2020
2018
Q4
$1.6M Buy
+16,590
New +$1.76M ﹤0.01% 1984
2018
Q3
Sell
-14,972
Closed -$1.76M 5368
2018
Q2
$1.64M Sell
14,972
-124,484
-89% -$13.3M ﹤0.01% 2171
2018
Q1
$14.9M Sell
139,456
-172,089
-55% -$19.1M 0.04% 393
2017
Q4
$33.3M Sell
311,545
-302,897
-49% -$32.4M 0.1% 184
2017
Q3
$68.3M Buy
614,442
+484,518
+373% +$51.8M 0.22% 82
2017
Q2
$13.4M Sell
129,924
-98,985
-43% -$9.75M 0.05% 342
2017
Q1
$22.4M Sell
228,909
-312,714
-58% -$29.9M 0.1% 172
2016
Q4
$47.9M Buy
541,623
+512,448
+1,756% +$46.6M 0.21% 83
2016
Q3
$2.81M Buy
29,175
+24,609
+539% +$2.34M 0.01% 927
2016
Q2
$392K Sell
4,566
-805,215
-99% -$72.2M ﹤0.01% 3006
2016
Q1
$70.4M Buy
809,781
+750,747
+1,272% +$67.1M 0.39% 41
2015
Q4
$6.66M Sell
59,034
-200,634
-77% -$21.8M 0.04% 387
2015
Q3
$26.3M Buy
259,668
+183,372
+240% +$22M 0.16% 105
2015
Q2
$9.38M Buy
76,296
+65,565
+611% +$7.85M 0.06% 263
2015
Q1
$1.23M Sell
10,731
-358,881
-97% -$39.6M 0.01% 1221
2014
Q4
$37.4M Buy
369,612
+365,790
+9,571% +$35.5M 0.28% 53
2014
Q3
$349K Buy
+3,822
New +$335K ﹤0.01% 1758
2014
Q2
Sell
-51,000
Closed -$4.02M 2812
2014
Q1
$4.02M Buy
+51,000
New +$4.25M 0.04% 300
2013
Q3
Sell
-10,782
Closed -$706K 2888
2013
Q2
$625K Buy
+10,782
New +$623K 0.01% 1249

Other funds holding IBB

Jane Street's IBB Position: Q1 2026 in Review

Jane Street reduced its iShares Biotechnology ETF (IBB) stake by 98% in Q1 2026, selling an estimated $19.3M and leaving 1,907 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #9087.

Jane Street first reported a position in IBB in Q2 2013 and has held it in 47 quarters since. The position peaked at $258M in Q4 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Jane Street held 1,907 shares of iShares Biotechnology ETF worth $322K as of Q1 2026.
  • Jane Street sold 112,844 iShares Biotechnology ETF shares in Q1 2026, an estimated $19.3M.
  • iShares Biotechnology ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9087 holding.
  • Jane Street first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 47 quarters since.
  • Jane Street's iShares Biotechnology ETF position peaked at $258M in Q4 2024.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.